Tailored Solutions
Strategic leadership, without the full-time overhead.
I work with MedTech and digital health teams on a fractional or project basis. My offerings include executive-level insight and execution across product, commercialization, and strategy; ensuring that your company operates at its peak performance during critical phases of your company's growth and achieves lasting success.
Product & Portfolio Strategy
Build the right product at the right time—with a roadmap that aligns across teams, markets, and milestones.
​
I help MedTech & HealthTech teams define, prioritize, and sequence product decisions. From hardware to software, I bring CPO-level clarity to what you build, when you build it, and why it matters to your market.
​
-
Creating product strategies that balance clinical, commercial, and technical needs
-
Prioritizing features and timing based on regulatory and market readiness
-
Aligning internal stakeholders around a shared product vision
-
Supporting portfolio planning across multiple assets or platforms
Go-to-Market Strategy & Launch Execution
Translate your product vision into a clear, executable path to market.
​
I guide teams through launch with real-world strategy and execution—not theory. Whether you're planning first entry or expanding a product line, I make sure your launch plan is grounded in your capabilities, constraints, and growth targets.
​
-
Aligning product, regulatory, and commercial timelines to ensure on-time launch
-
Leading cross-functional execution from roadmap through rollout
-
Prioritizing features and messaging that resonate with real customer needs
-
Driving launch strategy that fits team, budget, and bandwidth
U.S. Market Entry & Commercial Strategy
Guiding U.S. entry with a practical lens on regulatory, reimbursement, and go-to-market demands.
​
I help global healthtech companies localize their product, value proposition, and commercialization model for U.S. entry. From regulatory expectations to clinical buying behavior, I bring the insights and structure needed to make your entry stick.
​
-
Adapting product strategy and messaging for U.S. stakeholders
-
Advising on reimbursement, pricing, and early channel access
-
Supporting regulatory, clinical, and market entry alignment
-
Acting as U.S.-based product/commercial lead in early growth phase
Product Repositioning & Brand Realignment
Fix the disconnect between your product and the market.
​
When your product isn’t converting, it's often a signal your brand isn’t aligned with the market anymore. I lead rebranding and relaunch efforts that reposition your product and reengage your audience—with messaging and visuals that finally land.
​
-
Translating technical value into clear, market-facing positioning
-
Overhauling messaging and narrative for clarity and credibility
-
Coordinating logo, visual identity, and brand language updates
-
Planning and executing relaunch strategies that build traction—not just noise
Regulatory Strategy for Market Access
Shape your FDA strategy early—so your product design and evidence plan don’t derail you later.
​
I work with device teams to identify the right FDA pathway—510(k), De Novo, PMA, or Breakthrough—and align product strategy accordingly. That means smarter decisions up front about what you build, how you prove it, and how fast you can get to market.
​
-
Selecting the optimal regulatory pathway with risk/reward framing
-
Aligning evidence strategy with both clinical and commercial needs
-
Guiding product design decisions for regulatory feasibility
-
Supporting early regulatory positioning that keeps speed and scale in mind
Investor & Acquisition Strategy
From evaluating targets to preparing for exit—I help both sides make smarter moves.
​
I work with healthtech investors and operators to assess acquisition opportunities, align on commercial potential, and build strategy that holds up under scrutiny. Whether you’re preparing for a raise, assessing a target, or getting ready for diligence, I bring structure, insight, and real-world market logic to the table.
​
-
Evaluating acquisition targets for market fit, commercial viability, and risk
-
Supporting investor and operator due diligence with strategy-first assessments
-
Building investor-ready pro formas and use-of-funds strategies
-
Refining investor decks with clear commercial logic—not just surface polish